Applications the Drug Selsoviet with a Combination of Retinal amine in Retinal Dystrophy

Authors

  • Usmanova Tulganoy Jaloliddinovna Andijan State Medical Institute

DOI:

https://doi.org/10.62480/tjms.2022.vol7.pp137-139

Keywords:

Retinal dystrophy, OCT, Goniolinza

Abstract

The article explains the scientific significance of retinal dystrophy. An actual problem in ophthalmology at the present time is retinal dystrophy (DS). This is due to the progressive increase in the incidence of this pathology.

References

Bernstein P., Khachik F., Carvalho L. et al. //Exp.Eye.Res. - 2001- № 3- P. 215- 223.

Berendschot T.//Invest. Ophthalmol.Vis.Sci. - 2000. - Vol. 41, № 11. - P. 3322.3326.

Downloads

Published

2022-04-28

Issue

Vol. 7 (2022): TJMS

Section

Articles

License

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

User Rights

Under the Creative Commons Attribution-NonCommercial 4.0 International (CC-BY-NC), the author (s) and users are free to share (copy, distribute and transmit the contribution).

Rights of Authors

Authors retain the following rights:
1. Copyright and other proprietary rights relating to the article, such as patent rights,
2. the right to use the substance of the article in future works, including lectures and books,
3. the right to reproduce the article for own purposes, provided the copies are not offered for sale,
4. the right to self-archive the article.

How to Cite

Applications the Drug Selsoviet with a Combination of Retinal amine in Retinal Dystrophy. (2022). Texas Journal of Medical Science, 7, 137-139. https://doi.org/10.62480/tjms.2022.vol7.pp137-139